Literature DB >> 17333161

Idiopathic inflammatory-demyelinating diseases of the central nervous system.

A Rovira Cañellas1, A Rovira Gols, J Río Izquierdo, M Tintoré Subirana, X Montalban Gairin.   

Abstract

Idiopathic inflammatory-demyelinating diseases (IIDDs) include a broad spectrum of central nervous system disorders that can usually be differentiated on the basis of clinical, imaging, laboratory and pathological findings. However, there can be a considerable overlap between at least some of these disorders, leading to misdiagnoses or diagnostic uncertainty. The relapsing-remitting and secondary progressive forms of multiple sclerosis (MS) are the most common IIDDs. Other MS phenotypes include those with a progressive course from onset (primary progressive and progressive relapsing) or with a benign course continuing for years after onset (benign MS). Uncommon forms of IIDDs can be classified clinically into: (1) fulminant or acute IIDDs, such as the Marburg variant of MS, Baló's concentric sclerosis, Schilder's disease, and acute disseminated encephalomyelitis; (2) monosymptomatic IIDDs, such as those involving the spinal cord (transverse myelitis), optic nerve (optic neuritis) or brainstem and cerebellum; and (3) IIDDs with a restricted topographical distribution, including Devic's neuromyelitis optica, recurrent optic neuritis and relapsing transverse myelitis. Other forms of IIDD, which are classified clinically and radiologically as pseudotumoral, can have different forms of presentation and clinical courses. Although some of these uncommon IIDDs are variants of MS, others probably correspond to different entities. MR imaging of the brain and spine is the imaging technique of choice for diagnosing these disorders, and together with the clinical and laboratory findings can accurately classify them. Precise classification of these disorders may have relevant prognostic and treatment implications, and might be helpful in distinguishing them from tumoral or infectious lesions, avoiding unnecessary aggressive diagnostic or therapeutic procedures.

Entities:  

Mesh:

Year:  2007        PMID: 17333161     DOI: 10.1007/s00234-007-0216-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.995


  108 in total

Review 1.  The clinico-radiological paradox in multiple sclerosis revisited.

Authors:  Frederik Barkhof
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

2.  Clinically definite multiple sclerosis after radiological Schilder-like onset.

Authors:  J Sastre-Garriga; A Rovira; J Río; M Tintoré; E Grivé; X Montalban
Journal:  J Neurol       Date:  2003-07       Impact factor: 4.849

3.  Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.

Authors:  Heinz Wiendl; Robert Weissert; Ulrich Herrlinger; Hilmar Krapf; Wilhelm Küker
Journal:  Eur Neurol       Date:  2005       Impact factor: 1.710

4.  Neuromyelitis optica.

Authors:  Jérôme de Seze
Journal:  Arch Neurol       Date:  2003-09

5.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

6.  Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange.

Authors:  Yang Mao-Draayer; Steven Braff; William Pendlebury; Hillel Panitch
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

7.  Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord.

Authors:  A Campi; S Pontesilli; S Gerevini; G Scotti
Journal:  Neuroradiology       Date:  2000-09       Impact factor: 2.804

8.  [Necrotic aspects of multiple sclerosis and Schilder's disease (author's transl)].

Authors:  F Lhermitte; R Escourolle; J J Hauw; F Gray; M Serdaru; O Lyon-Caen
Journal:  Rev Neurol (Paris)       Date:  1981       Impact factor: 2.607

9.  Serial proton spectroscopy, magnetization transfer ratio and T 2 relaxation in pseudotumoral demyelinating lesions.

Authors:  M Gràcia Cucurella; Alex Rovira; Elisenda Grivé; Mar Tintoré; Xavier Montalban; Julio Alonso
Journal:  NMR Biomed       Date:  2002-06       Impact factor: 4.044

Review 10.  Imaging the optic nerve in multiple sclerosis.

Authors:  M A Rocca; S J Hickman; L Bö; F Agosta; D H Miller; G Comi; M Filippi
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

View more
  31 in total

1.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

Review 2.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

Review 3.  Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors:  Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-12       Impact factor: 5.749

4.  Neuroprotective effects of gypenosides in experimental autoimmune optic neuritis.

Authors:  Hong-Kan Zhang; Yuan Ye; Zhen-Ni Zhao; Kai-Jun Li; Yi Du; Qiu-Ming Hu; Jian-Feng He
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

5.  Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  Mike P Wattjes; Michael Harzheim; Götz G Lutterbey; Manuela Bogdanow; Stephan Schmidt; Hans H Schild; Frank Träber
Journal:  Neuroradiology       Date:  2007-11-03       Impact factor: 2.804

6.  Early anisotropy changes in the corpus callosum of patients with optic neuritis.

Authors:  M Bester; C Heesen; S Schippling; R Martin; X-Q Ding; B Holst; J Fiehler
Journal:  Neuroradiology       Date:  2008-05-06       Impact factor: 2.804

Review 7.  Vertigo and autoimmunity.

Authors:  Roberto Bovo; Andrea Ciorba; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-16       Impact factor: 2.503

8.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

Review 9.  High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

Authors:  Mike P Wattjes; Frederik Barkhof
Journal:  Neuroradiology       Date:  2009-03-11       Impact factor: 2.804

Review 10.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.